DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.373
EU - Europa 3.300
AS - Asia 1.591
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 8
SA - Sud America 4
Totale 11.295
Nazione #
US - Stati Uniti d'America 6.353
PL - Polonia 1.324
CN - Cina 858
UA - Ucraina 631
DE - Germania 379
IT - Italia 314
SG - Singapore 274
HK - Hong Kong 183
FI - Finlandia 168
GB - Regno Unito 157
IE - Irlanda 108
FR - Francia 90
TR - Turchia 89
IN - India 62
VN - Vietnam 62
CZ - Repubblica Ceca 32
BE - Belgio 25
ID - Indonesia 22
RU - Federazione Russa 21
CA - Canada 16
ES - Italia 16
SE - Svezia 16
TW - Taiwan 10
AU - Australia 9
EU - Europa 9
BD - Bangladesh 8
NL - Olanda 8
IR - Iran 5
AR - Argentina 3
IL - Israele 3
JP - Giappone 3
KR - Corea 3
MA - Marocco 3
SD - Sudan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
MU - Mauritius 2
MX - Messico 2
PK - Pakistan 2
SA - Arabia Saudita 2
AL - Albania 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
Totale 11.295
Città #
Warsaw 1.323
Fairfield 1.025
Woodbridge 797
Ashburn 495
Houston 494
Jacksonville 475
Cambridge 412
Ann Arbor 394
Seattle 392
Wilmington 364
Chandler 288
Singapore 235
Princeton 201
Hong Kong 179
Nanjing 168
Beijing 143
Dublin 107
Brescia 100
Dearborn 95
Helsinki 91
Istanbul 84
New York 82
Dong Ket 62
Changsha 53
Nanchang 53
Shanghai 48
Jinan 40
Shenyang 40
Milan 39
San Diego 37
Hebei 36
Des Moines 35
Jiaxing 32
Lancaster 32
Tianjin 30
Brussels 25
Munich 25
Boardman 24
Hangzhou 24
Jakarta 22
Kunming 21
San Mateo 21
Taizhou 20
Brno 19
San Francisco 18
Ningbo 17
London 16
Lanzhou 15
Leawood 15
Vieste 15
Augusta 14
Haikou 13
Los Angeles 13
Olomouc 13
Seveso 12
Phoenix 11
Verona 11
Barcelona 10
Fuzhou 10
Norwalk 10
Zhengzhou 10
Guangzhou 9
Walnut 9
Taiyuan 8
Toronto 8
Castenedolo 7
Kilburn 7
Orange 6
Rome 6
Chongqing 5
Indiana 5
Manchester 5
Redwood City 5
Sondrio 5
Amsterdam 4
Buffalo 4
Changchun 4
Falkenstein 4
Hefei 4
Hounslow 4
Hsinchu 4
Melbourne 4
Monmouth Junction 4
Murcia 4
Nürnberg 4
Ottawa 4
Prescot 4
Strasbourg 4
Taipei 4
Wandsworth 4
Ardabil 3
Bologna 3
Buenos Aires 3
Fremont 3
Kocaeli 3
Lappeenranta 3
Markham 3
Montecassiano 3
Santa Clara 3
Sydney 3
Totale 9.084
Nome #
Comparative analysis of mesenchymal stromal cells biological properties 290
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 252
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 250
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 248
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 235
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 225
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 224
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 216
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 212
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 210
Clinical potentials of human pluripotent stem cells 200
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 200
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 189
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 185
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 163
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 160
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 158
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 153
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 149
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 141
MEMS force microactuator with displacement sensing for mechanobiology experiments 141
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 141
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 134
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 134
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 132
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 131
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 130
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 125
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 125
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 124
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 122
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 122
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 119
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 118
Using iPS cells toward the understanding of parkinson'€™s disease 118
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 117
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 115
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 115
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 114
iPS, organoids and 3D models as advanced tools for in vitro toxicology 114
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 114
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 113
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 111
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 110
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 109
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 107
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 106
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 105
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 105
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 105
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 103
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 102
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 101
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 100
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 100
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 100
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 100
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 97
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 96
Fibroblast growth factor-2 in angiogenesis 94
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 94
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 94
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 94
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 92
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 91
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 91
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 91
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 91
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 91
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 90
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 89
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 86
iPS technology as a tool to investigate atrial fibrillation. 86
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 85
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 84
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 82
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 81
Preliminary report: hiPSC reprogramming and karyotypic studies 78
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 77
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 76
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 73
Atrial fibrillation modeling with iPSC derived cardiomyocyte 72
hiPSC reprogramming and karyotypic alterations: a brief report 72
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 69
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 67
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 66
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 64
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 62
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 62
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 62
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 61
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 58
iPS technology as a tool to investigate atrial fibrillation 56
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 56
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 46
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 44
Fat-derived mesenchymal stromal cells: different sources, different properties 41
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 41
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 32
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 23
Totale 11.499
Categoria #
all - tutte 46.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.475 0 0 0 0 249 399 371 376 302 433 167 178
2020/20211.971 72 250 82 234 98 172 108 214 235 174 211 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/2025501 26 19 5 280 171 0 0 0 0 0 0 0
Totale 11.547